Mankind Pharma to hold Q2 & H1 FY26 investor call November 6

Mankind Pharma Limited has announced an investor conference call to discuss its financial results for the second quarter and first half of the fiscal year 2026. The call is scheduled for Thursday, November 6, 2025, from 06:00 PM to 07:00 PM IST. Interested parties can access the call via universal dial-in numbers +91 22 6280 1102 or +91 22 7115 8003. International toll-free options include USA: 18667462133, UK: 08081011573, Singapore: 8001012045, and Hong Kong: 800964448.

The conference call will feature key members of Mankind Pharma's senior management, including rajeev juneja, vice chairman & managing director; sheetal arora, chief executive officer & whole time director; arjun juneja, chief operating officer; sudipta roy, senior president – sales & marketing; ashutosh dhawan, global chief financial officer; prakash agarwal, president (strategy); and abhishek agarwal, head - investor relations & avp - strategy.

To avoid wait times, participants are encouraged to pre-register for the call. For further details or inquiries, investors can contact abhishek agarwal at investor.relations@mankindpharma.com or by phone at 011-46846700. Adfactors PR representatives, snighter albuquerque and smit shah, are also available for media inquiries.